Matthew Hamilton Rosenberg’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2K Sell
315
-9
-3% -$592 ﹤0.01% 553
2026
Q1
$23.1K Sell
324
-14
-4% -$1.1K ﹤0.01% 529
2025
Q4
$27.7K Hold
338
0.01% 499
2025
Q3
$25.4K Sell
338
-467
-58% -$34.8K 0.01% 506
2025
Q2
$59.6K Sell
805
-90
-10% -$6.26K 0.01% 414
2025
Q1
$72.2K Buy
895
+184
+26% +$15.8K 0.02% 363
2024
Q4
$55.6K Buy
711
+384
+117% +$32.6K 0.01% 404
2024
Q3
$30.7K Buy
327
+57
+21% +$4.78K 0.01% 501
2024
Q2
$20.6K Sell
270
-158
-37% -$12.9K 0.01% 527
2024
Q1
$38.3K Sell
428
-10
-2% -$832 0.01% 461
2023
Q4
$33.9K Buy
438
+60
+16% +$4.2K 0.01% 477
2023
Q3
$25.7K Buy
378
+10
+3% +$728 0.01% 497
2023
Q2
$29.9K Buy
368
+90
+32% +$7.18K 0.01% 498
2023
Q1
$22.8K Buy
+278
New +$19.8K 0.01% 569

Other funds holding GEHC

Matthew Hamilton Rosenberg's GEHC Position: Q2 2026 in Review

Matthew Hamilton Rosenberg reduced its GE HealthCare (GEHC) stake by 2.8% in Q2 2026, selling an estimated $592 and leaving 315 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Matthew Hamilton Rosenberg first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $72.2K in Q1 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Matthew Hamilton Rosenberg held 315 shares of GE HealthCare worth $20.2K as of Q2 2026.
  • Matthew Hamilton Rosenberg sold 9 GE HealthCare shares in Q2 2026, an estimated $592.
  • GE HealthCare made up ﹤0.01% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #553 holding.
  • Matthew Hamilton Rosenberg first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Matthew Hamilton Rosenberg's GE HealthCare position peaked at $72.2K in Q1 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.